Biohit Oyj (BIOBV.HE)
EUR 2.23
(-2.19%)
EUR 2.23
(-2.19%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 900 Thousand EUR | -2.17% |
| 2022 | 920 Thousand EUR | 22.67% |
| 2021 | 750 Thousand EUR | -16.94% |
| 2020 | 903 Thousand EUR | -8.79% |
| 2019 | 990 Thousand EUR | 19.85% |
| 2018 | 826 Thousand EUR | 21.29% |
| 2017 | 681 Thousand EUR | -21.18% |
| 2016 | 864 Thousand EUR | 35.64% |
| 2015 | 637 Thousand EUR | -21.94% |
| 2014 | 816 Thousand EUR | 26.32% |
| 2013 | 646 Thousand EUR | 45.5% |
| 2012 | 444 Thousand EUR | 39.18% |
| 2011 | 319 Thousand EUR | -93.91% |
| 2010 | 5.23 Million EUR | 1.95% |
| 2009 | 5.13 Million EUR | -10.94% |
| 2008 | 5.76 Million EUR | 2.61% |
| 2007 | 5.62 Million EUR | -2.58% |
| 2006 | 5.77 Million EUR | 25.89% |
| 2005 | 4.58 Million EUR | 28.58% |
| 2004 | 3.56 Million EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.1 Million EUR | 0.0% |
| 2024 Q1 | 1.1 Million EUR | 22.22% |
| 2023 Q3 | 890 Thousand EUR | 27.14% |
| 2023 FY | 900 Thousand EUR | -2.17% |
| 2023 Q2 | 700 Thousand EUR | 0.0% |
| 2023 Q4 | 900 Thousand EUR | 1.12% |
| 2023 Q1 | 700 Thousand EUR | -23.91% |
| 2022 Q4 | 920 Thousand EUR | 0.0% |
| 2022 FY | 920 Thousand EUR | 22.67% |
| 2022 Q3 | 920 Thousand EUR | 15.0% |
| 2022 Q2 | 800 Thousand EUR | 0.0% |
| 2022 Q1 | 800 Thousand EUR | 6.67% |
| 2021 Q3 | 750 Thousand EUR | -25.0% |
| 2021 Q2 | 1 Million EUR | 0.0% |
| 2021 Q1 | 1 Million EUR | 10.74% |
| 2021 FY | 750 Thousand EUR | -16.94% |
| 2021 Q4 | 750 Thousand EUR | 0.0% |
| 2020 Q1 | 1.3 Million EUR | 31.31% |
| 2020 Q2 | 1.3 Million EUR | 0.0% |
| 2020 Q3 | 903 Thousand EUR | -30.54% |
| 2020 Q4 | 903 Thousand EUR | 0.0% |
| 2020 FY | 903 Thousand EUR | -8.79% |
| 2019 Q2 | 900 Thousand EUR | 0.0% |
| 2019 FY | 990 Thousand EUR | 19.85% |
| 2019 Q1 | 900 Thousand EUR | 8.96% |
| 2019 Q4 | 990 Thousand EUR | 0.0% |
| 2019 Q3 | 990 Thousand EUR | 10.0% |
| 2018 Q2 | 700 Thousand EUR | 0.0% |
| 2018 Q3 | 826 Thousand EUR | 18.0% |
| 2018 FY | 826 Thousand EUR | 21.29% |
| 2018 Q1 | 700 Thousand EUR | 2.79% |
| 2018 Q4 | 826 Thousand EUR | 0.0% |
| 2017 Q3 | 681 Thousand EUR | -24.33% |
| 2017 FY | 681 Thousand EUR | -21.18% |
| 2017 Q2 | 900 Thousand EUR | 0.0% |
| 2017 Q4 | 681 Thousand EUR | 0.0% |
| 2017 Q1 | 900 Thousand EUR | 4.17% |
| 2016 Q4 | 864 Thousand EUR | 0.0% |
| 2016 Q1 | 700 Thousand EUR | 9.89% |
| 2016 Q2 | 700 Thousand EUR | 0.0% |
| 2016 Q3 | 864 Thousand EUR | 23.43% |
| 2016 FY | 864 Thousand EUR | 35.64% |
| 2015 Q2 | 700 Thousand EUR | -22.22% |
| 2015 Q1 | 900 Thousand EUR | 10.29% |
| 2015 FY | 637 Thousand EUR | -21.94% |
| 2015 Q4 | 637 Thousand EUR | -9.0% |
| 2015 Q3 | 700 Thousand EUR | 0.0% |
| 2014 Q3 | 1 Million EUR | 25.0% |
| 2014 FY | 816 Thousand EUR | 26.32% |
| 2014 Q4 | 816 Thousand EUR | -18.4% |
| 2014 Q2 | 800 Thousand EUR | 14.29% |
| 2014 Q1 | 700 Thousand EUR | 8.36% |
| 2013 Q1 | 500 Thousand EUR | 12.61% |
| 2013 Q3 | 600 Thousand EUR | -14.29% |
| 2013 Q4 | 646 Thousand EUR | 7.67% |
| 2013 Q2 | 700 Thousand EUR | 40.0% |
| 2013 FY | 646 Thousand EUR | 45.5% |
| 2012 Q4 | 444 Thousand EUR | 11.0% |
| 2012 Q2 | 300 Thousand EUR | -25.0% |
| 2012 FY | 444 Thousand EUR | 39.18% |
| 2012 Q3 | 400 Thousand EUR | 33.33% |
| 2012 Q1 | 400 Thousand EUR | 25.39% |
| 2011 Q1 | 5.5 Million EUR | 5.0% |
| 2011 Q3 | 6.4 Million EUR | 10.34% |
| 2011 Q2 | 5.8 Million EUR | 5.45% |
| 2011 Q4 | 319 Thousand EUR | -95.02% |
| 2011 FY | 319 Thousand EUR | -93.91% |
| 2010 Q1 | 5.3 Million EUR | 3.15% |
| 2010 Q2 | 5.2 Million EUR | -1.89% |
| 2010 FY | 5.23 Million EUR | 1.95% |
| 2010 Q3 | 5.2 Million EUR | 0.0% |
| 2010 Q4 | 5.23 Million EUR | 0.73% |
| 2009 Q4 | 5.13 Million EUR | 0.0% |
| 2009 FY | 5.13 Million EUR | -10.94% |
| 2008 FY | 5.76 Million EUR | 2.61% |
| 2007 FY | 5.62 Million EUR | -2.58% |
| 2006 FY | 5.77 Million EUR | 25.89% |
| 2005 FY | 4.58 Million EUR | 28.58% |
| 2004 FY | 3.56 Million EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Herantis Pharma Oyj | -237.97 Thousand EUR | 478.197% |
| Nanoform Finland Oyj | 218.26 Thousand EUR | -312.343% |